Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Andrew Hardaway

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|August 3, 2023
Turning the tide on obesity?Cynthia M Bulik, J Andrew Hardaway
Advances in Genomics and Genetics|March 26, 2016
Genetics and Epigenetics of Eating DisordersZeynep Yilmaz, J Andrew Hardaway, Cynthia M Bulik
Endocrinology|January 31, 2025
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central AmygdalaMiguel Duran, Jennifer R Willis, Nilay Dalvi, et al.
Pharmacological Research|January 1, 2026
IUPHAR Review: From Foe to Friend: Repurposing Glucagon to Treat Obesity and Type 2 DiabetesAndrew J Elmendorf, Mostafa Yousefian, Il-Man Kim, et al.
Molecular Metabolism|June 18, 2026
The central amygdala gates exogenous glucagon-like peptide 1 signalsMiguel Duran, Ningxiang Zeng, Elam J Cutts, et al.
Frontiers in Behavioral Neuroscience|January 10, 2022
Anatomical and Functional Characterization of Central Amygdala Glucagon-Like Peptide 1 Receptor Expressing NeuronsNingxiang Zeng, Elam J Cutts, Christian B Lopez, et al.
Scientific Reports|August 17, 2023
Bile acids modulate reinstatement of cocaine conditioned place preference and accumbal dopamine dynamics without compromising appetitive learningDaniele Zanella, Nicholas K Smith, J Andrew Hardaway, et al.
Nature Neuroscience|May 6, 2022
Genetics and neurobiology of eating disordersCynthia M Bulik, Jonathan R I Coleman, J Andrew Hardaway, et al.
Plos One|May 15, 2019
Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1Sarah B Robinson, Osama Refai, J Andrew Hardaway, et al.
Neurochemistry International|February 7, 2016
Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivoDaniel P Bermingham, J Andrew Hardaway, Chelsea L Snarrenberg, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|August 3, 2023
Turning the tide on obesity?Cynthia M Bulik, J Andrew Hardaway
Advances in Genomics and Genetics|March 26, 2016
Genetics and Epigenetics of Eating DisordersZeynep Yilmaz, J Andrew Hardaway, Cynthia M Bulik
Endocrinology|January 31, 2025
Integration of Glucagon-Like Peptide 1 Receptor Actions Through the Central AmygdalaMiguel Duran, Jennifer R Willis, Nilay Dalvi, et al.
Pharmacological Research|January 1, 2026
IUPHAR Review: From Foe to Friend: Repurposing Glucagon to Treat Obesity and Type 2 DiabetesAndrew J Elmendorf, Mostafa Yousefian, Il-Man Kim, et al.
Molecular Metabolism|June 18, 2026
The central amygdala gates exogenous glucagon-like peptide 1 signalsMiguel Duran, Ningxiang Zeng, Elam J Cutts, et al.
Frontiers in Behavioral Neuroscience|January 10, 2022
Anatomical and Functional Characterization of Central Amygdala Glucagon-Like Peptide 1 Receptor Expressing NeuronsNingxiang Zeng, Elam J Cutts, Christian B Lopez, et al.
Scientific Reports|August 17, 2023
Bile acids modulate reinstatement of cocaine conditioned place preference and accumbal dopamine dynamics without compromising appetitive learningDaniele Zanella, Nicholas K Smith, J Andrew Hardaway, et al.
Nature Neuroscience|May 6, 2022
Genetics and neurobiology of eating disordersCynthia M Bulik, Jonathan R I Coleman, J Andrew Hardaway, et al.
Plos One|May 15, 2019
Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1Sarah B Robinson, Osama Refai, J Andrew Hardaway, et al.
Neurochemistry International|February 7, 2016
Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivoDaniel P Bermingham, J Andrew Hardaway, Chelsea L Snarrenberg, et al.
Pageof 3